Chloroquine Injection 40mg/ml Manufacturer

Product Overview

Sanjar Pharma manufactures Chloroquine Injection 40mg/ml at its WHO-GMP compliant sterile injectable manufacturing facility. The product is manufactured using validated pharmaceutical processes, controlled production environments, and documented quality systems designed to support product consistency, sterility, and regulatory compliance.

Chloroquine belongs to the antimalarial category and is widely utilized within hospital treatment programs, healthcare institutions, public health procurement systems, and pharmaceutical supply chains requiring high-quality sterile injectable products. Manufacturing is supported by advanced analytical testing, microbiological monitoring, and quality assurance controls.

Supported by modern sterile manufacturing infrastructure and export-oriented pharmaceutical operations, Sanjar Pharma supplies Chloroquine Injection to pharmaceutical companies, distributors, healthcare institutions, government procurement agencies, and international markets.